Angelo Corso Faini

484 total citations
20 papers, 328 citations indexed

About

Angelo Corso Faini is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Angelo Corso Faini has authored 20 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Angelo Corso Faini's work include Calcium signaling and nucleotide metabolism (9 papers), Adenosine and Purinergic Signaling (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Angelo Corso Faini is often cited by papers focused on Calcium signaling and nucleotide metabolism (9 papers), Adenosine and Purinergic Signaling (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Angelo Corso Faini collaborates with scholars based in Italy, United States and Belarus. Angelo Corso Faini's co-authors include Fabio Malavasi, Alberto L. Horenstein, Fabio Morandi, Danilo Marimpietri, Francesco Lanza, Irma Airoldi, Roberto Gramignoli, Enrico Maffini, Nicola Giuliani and Barbara Castella and has published in prestigious journals such as Physiological Reviews, The Journal of Immunology and Cancer Research.

In The Last Decade

Angelo Corso Faini

16 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Corso Faini Italy 10 127 124 96 95 68 20 328
Daniela DiFranco Italy 8 86 0.7× 88 0.7× 173 1.8× 285 3.0× 72 1.1× 10 497
Lanier H. Ayscue United States 10 87 0.7× 97 0.8× 148 1.5× 46 0.5× 107 1.6× 11 396
U Schmücker Germany 6 52 0.4× 89 0.7× 139 1.4× 166 1.7× 48 0.7× 10 401
Kim Rosenthal United States 8 71 0.6× 128 1.0× 148 1.5× 113 1.2× 9 0.1× 10 331
Jennifer M. Burg United States 8 37 0.3× 136 1.1× 156 1.6× 237 2.5× 21 0.3× 16 481
Ligen Liu China 11 26 0.2× 89 0.7× 168 1.8× 113 1.2× 142 2.1× 29 372
Cinzia Bologna Italy 9 50 0.4× 101 0.8× 131 1.4× 115 1.2× 23 0.3× 17 303
Audrey Paoletti France 10 19 0.1× 43 0.3× 83 0.9× 120 1.3× 24 0.4× 17 353
Claude Hattab France 15 21 0.2× 47 0.4× 192 2.0× 59 0.6× 178 2.6× 28 461
Sebastian E. Koschade Germany 10 20 0.2× 37 0.3× 188 2.0× 24 0.3× 77 1.1× 24 328

Countries citing papers authored by Angelo Corso Faini

Since Specialization
Citations

This map shows the geographic impact of Angelo Corso Faini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Corso Faini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Corso Faini more than expected).

Fields of papers citing papers by Angelo Corso Faini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Corso Faini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Corso Faini. The network helps show where Angelo Corso Faini may publish in the future.

Co-authorship network of co-authors of Angelo Corso Faini

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Corso Faini. A scholar is included among the top collaborators of Angelo Corso Faini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Corso Faini. Angelo Corso Faini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Horenstein, Alberto L., Angelo Corso Faini, Fabio Morandi, et al.. (2025). Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects. Frontiers in Immunology. 16. 1519300–1519300. 3 indexed citations
3.
Kundnani, Deepali L., Francesca Agostini, Angelo Corso Faini, et al.. (2025). Characterization of a new mutation of mitochondrial ND6 gene in hepatocellular carcinoma and its effects on respiratory complex I. Scientific Reports. 15(1). 10925–10925. 1 indexed citations
4.
Vaisitti, Tiziana, Angelo Corso Faini, Roberta Camilla, et al.. (2024). Matching clinical and genetic data in pediatric patients at risk of developing cystic kidney disease. Pediatric Nephrology. 40(3). 743–753.
5.
Faini, Angelo Corso, Francesca Arruga, Michele Pinon, et al.. (2024). Genomic and Transcriptomic Profile of HNF1A-Mutated Liver Adenomas Highlights Molecular Signature and Potential Therapeutic Implications. International Journal of Molecular Sciences. 25(19). 10483–10483.
6.
Vaisitti, Tiziana, Angelo Corso Faini, Roberta Camilla, et al.. (2023). The role of genetic testing in the diagnostic workflow of pediatric patients with kidney diseases: the experience of a single institution. Human Genomics. 17(1). 10–10. 8 indexed citations
7.
Faini, Angelo Corso, Víctor Navarro-Tableros, Silvia Martini, et al.. (2023). Extracellular Vesicles in Liver Transplantation: Current Evidence and Future Challenges. International Journal of Molecular Sciences. 24(17). 13547–13547. 4 indexed citations
8.
Trotta, Luca, Angelo Corso Faini, Licia Peruzzi, et al.. (2023). Relevance of next generation sequencing (NGS) data re-analysis in the diagnosis of monogenic diseases leading to organ failure. BMC Medical Genomics. 16(1). 303–303.
9.
Marimpietri, Danilo, Irma Airoldi, Angelo Corso Faini, Fabio Malavasi, & Fabio Morandi. (2021). The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma. International Journal of Molecular Sciences. 22(8). 3964–3964. 11 indexed citations
10.
Horenstein, Alberto L., Angelo Corso Faini, & Fabio Malavasi. (2021). CD38 in the age of COVID-19: a medical perspective. Physiological Reviews. 101(4). 1457–1486. 39 indexed citations
11.
Malavasi, Fabio, Angelo Corso Faini, Fabio Morandi, et al.. (2021). Molecular dynamics of targeting CD38 in multiple myeloma. British Journal of Haematology. 193(3). 581–591. 22 indexed citations
12.
Horenstein, Alberto L., Angelo Corso Faini, Fabio Morandi, et al.. (2020). The Circular Life of Human CD38: From Basic Science to Clinics and Back. Molecules. 25(20). 4844–4844. 25 indexed citations
13.
Zannetti, Beatrice Anna, Angelo Corso Faini, Massimo Geuna, et al.. (2020). Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model. Cells. 9(12). 2666–2666. 11 indexed citations
14.
15.
16.
Morandi, Fabio, Alberto L. Horenstein, Valeria Quarona, et al.. (2018). Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations. The Journal of Immunology. 202(3). 724–735. 12 indexed citations
17.
Morandi, Fabio, Danilo Marimpietri, Alberto L. Horenstein, et al.. (2018). Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD+. OncoImmunology. 7(8). e1458809–e1458809. 68 indexed citations
18.
Ferrero, Enza, Angelo Corso Faini, & Fabio Malavasi. (2018). A phylogenetic view of the leukocyte ectonucleotidases. Immunology Letters. 205. 51–58. 15 indexed citations
19.
Castella, Barbara, Angelo Corso Faini, Fabio Morandi, et al.. (2018). Abstract 2122: Induction of structural and functional effects of myeloma cells after daratumumab treatment. Cancer Research. 78(13_Supplement). 2122–2122. 1 indexed citations
20.
Horenstein, Alberto L., Antonella Chillemi, Valeria Quarona, et al.. (2016). Antibody mimicry, receptors and clinical applications. Human Antibodies. 25(3-4). 75–85. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela DiFranco Breakdown of academic impact, for papers by Lanier H. Ayscue Breakdown of academic impact, for papers by U Schmücker Breakdown of academic impact, for papers by Kim Rosenthal Breakdown of academic impact, for papers by Jennifer M. Burg Breakdown of academic impact, for papers by Ligen Liu Breakdown of academic impact, for papers by Cinzia Bologna Breakdown of academic impact, for papers by Audrey Paoletti Breakdown of academic impact, for papers by Claude Hattab Breakdown of academic impact, for papers by Sebastian E. Koschade
Rankless by CCL
2026